Kymera Therapeutics, Inc 10-K for FY2022
Kymera Therapeutics, Inc. (KYMR)
10-K
2023-02-23
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
Kymera Therapeutics, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $46.83M
- down 35.7% from $72.83M a year earlier
- Net loss
- $154.81M
- compared with a net loss of $100.22M a year earlier
- Diluted EPS
- -$2.87
- compared with -$2.09 a year earlier